| Identification | Back Directory | [Name]
HIF2α-IN-2 | [CAS]
1672666-82-8 | [Synonyms]
HIF2α-IN-2
HIF-2α-IN-2
Benzonitrile, 3-fluoro-5-[[2-fluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl]oxy]-
HIF/HIF Prolyl-Hydroxylase,inhibit,HIFs,Hypoxia-inducible factors,Inhibitor,HIF-PH,HIF 2α IN 2,HIF2αIN2 | [Molecular Formula]
C17H13F2NO4S | [MDL Number]
MFCD33023214 | [MOL File]
1672666-82-8.mol | [Molecular Weight]
365.35 |
| Chemical Properties | Back Directory | [Boiling point ]
530.6±50.0 °C(Predicted) | [density ]
1.52±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 100 mg/mL (273.71 mM; Need ultrasonic) | [form ]
Solid | [pka]
12.48±0.40(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
HIF-2α-IN-2 is a hypoxia-inducible factors (HIF-2α) inhibitor extracted from patent WO2015035223A1, Compound 232, has an IC50 of 16 nM in scintillation proximity assay (SPA)[1]. | [References]
[1] Darryl David DIXON, et al. Aryl ethers and uses thereof. WO2015035223A1. |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|